V.T. Blok

The Inhibitory Effect of CD46, CD55, and CD59 on Complement Activation After Immunotherapeutic Treatment of Cervical Carcinoma Cells with Monoclonal Antibodies or Bispecific Monoclonal Antibodies

Kyra A. Gelderman, V.T. Blok, Gert Jan Fleuren et al. · Laboratory Investigation · 2002 · 77 citations

Cervical Carcinoma Cells, Immunology, Monoclonal Antibodies +8

Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.

Arko Gorter, V.T. Blok, Wim H.B. Haasnoot et al. · PubMed · 1996 · 75 citations

A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement

V.T. Blok, Mohamed R. Daha, Odette Tijsma et al. · The Journal of Immunology · 1998 · 53 citations · Full text

Parental Mab, Complement System, Cancer Immunosurveillance +14

A Possible Role of CD46 for the Protection In Vivo of Human Renal Tumor Cells from Complement-Mediated Damage

V.T. Blok, Mohamed R. Daha, Odette M H Tijsma et al. · Laboratory Investigation · 2000 · 51 citations · Full text

Cytokines Affect Resistance of Human Renal Tumour Cells to Complement‐Mediated Injury

V.T. Blok, Kyra A. Gelderman, Odette Tijsma et al. · Scandinavian Journal of Immunology · 2003 · 25 citations · Full text